C. Rathcke

发表

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes

H. Vestergaard, C. Rathcke, 2009, Cardiovascular diabetology.

NT-proBNP and Circulating Inflammation Markers in Prediction of a Normal Myocardial Scintigraphy in Patients with Symptoms of Coronary Artery Disease

H. Vestergaard, E. Kjøller, B. Zerahn, 2010, PloS one.

Intake of traditional Inuit diet vary in parallel with inflammation as estimated from YKL-40 and hsCRP in Inuit and non-Inuit in Greenland.

P. Laurberg, H. Vestergaard, S. Andersen, 2013, Atherosclerosis.

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria

L. Tarnow, H. Vestergaard, P. Rossing, 2009, Diabetes Care.

Effects of Roux-en-Y Gastric Bypass on Fasting and Postprandial Levels of the Inflammatory Markers YKL-40 and MCP-1 in Patients with Type 2 Diabetes and Glucose Tolerant Subjects

H. Vestergaard, S. Madsbad, C. Rathcke, 2013, Journal of obesity.

Increased YKL-40 expression in patients with carotid atherosclerosis.

H. Vestergaard, P. Aukrust, F. Brosstad, 2010, Atherosclerosis.

Plasma YKL-40 during pregnancy and gestational diabetes mellitus.

T. Vilsbøll, F. Knop, L. Bonde, 2015, Journal of reproductive immunology.

Association of Polymorphisms of the CHI3L1 Gene with Asthma and Atopy: A Populations-Based Study of 6514 Danish Adults

T. Hansen, O. Pedersen, J. Holmkvist, 2009, PloS one.

YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis

H. Vestergaard, C. Rathcke, 2006, Inflammation Research.

Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population.

H. Vestergaard, P. Hildebrandt, J. Faber, 2010, International journal of cardiology.

YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance

H. Vestergaard, J. Johansen, C. Rathcke, 2006, Inflammation Research.

Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes

T. Hansen, O. Pedersen, H. Eiberg, 2015, PloS one.

Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population

H. Vestergaard, P. Hildebrandt, J. Faber, 2010, Inflammation Research.

Variations of CHI3L1, Levels of the Encoded Glycoprotein YKL-40 and Prediction of Fatal and Non-fatal Ischemic Stroke

H. Vestergaard, A. Linneberg, C. Rathcke, 2012, PloS one.

Plasma YKL-40 levels are elevated in patients with chronic heart failure

G. Lip, H. Vestergaard, P. Hildebrandt, 2010, Scandinavian cardiovascular journal : SCJ.

Increased levels of the calcification marker Matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease

H. Vestergaard, B. Zerahn, C. Rathcke, 2010, Cardiovascular diabetology.

The Association between Genetic Variations of CHI3L1, Levels of the Encoded Glycoprotein YKL-40 and the Lipid Profile in a Danish Population

H. Vestergaard, A. Linneberg, T. Skaaby, 2012, PloS one.

High YKL-40 levels predict mortality in patients with type 2 diabetes.

H. Parving, H. Vestergaard, P. Rossing, 2012, Diabetes research and clinical practice.

Variation in CHI3LI in Relation to Type 2 Diabetes and Related Quantitative Traits

T. Hansen, O. Pedersen, T. Jørgensen, 2009, PloS one.

YKL-40-an emerging biomarker in cardiovascular disease and diabetes

H. Vestergaard, C. Rathcke, 2015 .

Increased levels of the calcification marker Matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease

H. Vestergaard, B. Zerahn, C. Rathcke, 2010, Cardiovascular diabetology.

Intake of traditional Inuit diet vary in parallel with inflammation as estimated from YKL-40 and hsCRP in Inuit and non-Inuit in Greenland.

P. Laurberg, H. Vestergaard, Stig Andersen, 2013, Atherosclerosis.

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes

C. Rathcke, Henrik Vestergaard, Henrik Vestergaard, 2009, Cardiovascular diabetology.